A detailed history of Charles Schwab Investment Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 12,609,477 shares of ABT stock, worth $1.44 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares
12,609,477
Previous 12,619,799 0.08%
Holding current value
$1.44 Billion
Previous $1.31 Billion 9.63%
% of portfolio
0.28%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $1.03 Million - $1.22 Million
-10,322 Reduced 0.08%
12,609,477 $1.44 Billion
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $25.4 Million - $28.4 Million
252,522 Added 2.04%
12,619,799 $1.31 Billion
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $697,532 - $770,394
6,369 Added 0.05%
12,367,277 $1.41 Billion
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $18.7 Million - $22.9 Million
207,031 Added 1.7%
12,360,908 $1.36 Billion
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $3.07 Million - $3.69 Million
32,157 Added 0.27%
12,153,877 $1.18 Billion
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $2.25 Million - $2.51 Million
-22,318 Reduced 0.18%
12,121,720 $1.32 Billion
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $5.32 Million - $6.27 Million
54,953 Added 0.45%
12,144,038 $1.23 Billion
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $18.7 Million - $22 Million
197,018 Added 1.66%
12,089,085 $1.33 Billion
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $34.5 Million - $39.9 Million
356,171 Added 3.09%
11,892,067 $1.15 Billion
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $1.27 Million - $1.53 Million
12,423 Added 0.11%
11,535,896 $1.25 Billion
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $24.9 Million - $30.4 Million
218,683 Added 1.93%
11,523,473 $1.36 Billion
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $17 Million - $20.9 Million
147,560 Added 1.32%
11,304,790 $1.59 Billion
Q3 2021

Nov 16, 2021

SELL
$116.66 - $129.06 $1.79 Million - $1.98 Million
-15,354 Reduced 0.14%
11,157,230 $1.32 Billion
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $19.3 Million - $22.7 Million
182,441 Added 1.66%
11,172,584 $1.3 Billion
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $13.6 Million - $16 Million
124,683 Added 1.15%
10,990,143 $1.32 Billion
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $12.1 Million - $13.2 Million
-115,651 Reduced 1.05%
10,865,460 $1.19 Billion
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $38 Million - $46.1 Million
-414,585 Reduced 3.64%
10,981,111 $1.2 Billion
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $7.37 Million - $9.44 Million
-96,282 Reduced 0.84%
11,395,696 $1.04 Billion
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $232 Million - $339 Million
3,695,015 Added 47.39%
11,491,978 $907 Million
Q4 2019

Feb 07, 2020

BUY
$78.51 - $87.4 $8.46 Million - $9.42 Million
107,813 Added 1.4%
7,796,963 $677 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $2.88 Million - $3.12 Million
35,186 Added 0.46%
7,689,150 $643 Million
Q2 2019

Aug 09, 2019

BUY
$72.88 - $85.0 $14.5 Million - $16.9 Million
199,283 Added 2.67%
7,653,964 $644 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $18.1 Million - $21.9 Million
273,946 Added 3.82%
7,454,681 $596 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $6.54 Million - $7.41 Million
99,812 Added 1.41%
7,180,735 $519 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $3.17 Million - $3.82 Million
52,110 Added 0.74%
7,080,923 $519 Million
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $17.2 Million - $19 Million
-298,676 Reduced 4.08%
7,028,813 $429 Million
Q1 2018

May 07, 2018

BUY
$56.27 - $63.62 $18.9 Million - $21.4 Million
335,665 Added 4.8%
7,327,489 $439 Million
Q4 2017

Jan 17, 2018

BUY
$53.68 - $57.47 $44.8 Million - $47.9 Million
833,866 Added 13.54%
6,991,824 $399 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $296 Million - $330 Million
6,157,958
6,157,958 $329 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.